Saltar al contenido

303: From Freezer to Bedside: Controlling Cryopreservation Variability in Cell Therapy Manufacturing with Sean Werner - Part 1

10 de noviembre de 2026 · 22 min

Notas del episodio

The integrity of individual cells is the cornerstone of breakthrough cell and gene therapies—but translating lab discoveries into clinical success demands mastering cryopreservation challenges rarely discussed in depth.

Sean Werner, Chief Technology Officer of Cell Processing at BioLife Solutions,a leading provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets, has dedicated his career to safeguarding cell viability from the lab bench through to clinical application.

Topics discussed:

  • Sean Werner's unconventional career progression and early experiences in regenerative medicine (03:22)
  • The critical role of cryopreservation in cell and gene therapy product quality (05:59)
  • Biophysics of freezing: ice nucleation, supercooling, and their impact on cell viability (07:32)
  • Hidden pitfalls in cryopreservation, including ice recrystallization and osmotic stress (07:43)
  • Real-world challenges during clinical handling and thawing of cell therapies (11:18)
  • Why the commonly used -1°C per minute freeze rate is not universally optimal (13:09)
  • Difficulties in tracing clinical problems back to early cryopreservation choices (13:54)
  • Importance of evaluating long-term cell function, not just post-thaw viability (15:08)
  • Regulatory expectations around freeze-thaw processes in therapy manufacturing (16:34)

Smart insight: Success in cell therapy and advanced biologics is inseparable from mastery of cryopreservation. By adopting an experimental and data-driven mindset—questioning assumptions, customizing protocols, and measuring what truly matters—scientists can better fulfill that original promise: that a single cell, carefully protected, can change the course of medicine for patients worldwide.

If this episode has you rethinking freeze-thaw, here’s where to go next. Start with the science behind cryopreservation, then compare two takes on cryoprotectants: DMSO-free formulations and antifreeze-inspired chemistry.

  • Episodes 241 - 242: DMSO in Cell Therapy: Why Viability Scores Hide the Real Toxicity with Steve Oh
  • Episodes 161 - 162: How to Achieve 85%+ Cell Recovery Without DMSO’s Toxic Side Effects with Jeffrey Allen
  • Episodes 65 - 66: Freezing and Thawing Cells: the Science Behind Cryopreservation with Mark Davison
  • Episodes 129 - 130: Revolutionizing Cell Therapy Manufacturing: Reducing Costs to Reach More Patients with Jason Foster

Connect with Sean Werner:
Website: www.biolifesolutions.com
LinkedIn: https://www.linkedin.com/in/sean-werner-54688326/

Support the show

Todos los episodios de Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders

Ajustes

Visualización

Idioma

Determina qué emisoras ves primero en la página de inicio.

Historial

Las emisoras y episodios escuchados recientemente y tus últimas búsquedas solo se guardan en este navegador.

Avisos

Un breve aviso cuando un pódcast que sigues tiene un episodio nuevo. Puedes desactivar pódcast concretos con la campana de su página.

Cuenta

Guarda tus favoritos: en la app y en la web.

Atajos de teclado

/
Abrir búsqueda
Espacio
Reproducir o pausar
← →
En el reproductor: 15 s atrás, 30 s adelante (episodios) · en una fila: siguiente tarjeta
↑ ↓
En una fila: destino dentro de la tarjeta
Inicio / Fin
En una fila: primera o última tarjeta
Esc
Cerrar ventana o menú
?
Este resumen
Reproduciendo ahora

Ir a la emisora

A continuación

    Añade episodios con «A continuación»: sonarán después del episodio actual.